HCA Holdings, Inc. (NYSE:HCA) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Tuesday.

According to Zacks, “HCA Healthcare’s shares have lost value in six months' time. The company continues to suffer from weak commercial business that has faced declining volumes of admissions over the last four to five quarters. Its high bad debts and disappointing international business are the other headwinds. The company has also trimmed its 2017 guidance which bothers us. The stock has seen the Zacks Consensus Estimate for current-year earnings being revised 2% downward over the last 60 days. Its top-line has been growing over the past several quarters on strong volumes and improved payor and service mix. A number of acquisitions made over the past many years have helped the company gain a strong foothold in the industry. “

A number of other equities analysts also recently issued reports on HCA. Argus initiated coverage on HCA Holdings in a research note on Wednesday, June 28th. They set a “buy” rating and a $100.00 price target for the company. BidaskClub downgraded HCA Holdings from a “hold” rating to a “sell” rating in a research note on Monday, July 24th. Bank of America Corporation downgraded HCA Holdings from a “buy” rating to a “neutral” rating and cut their price target for the company from $102.00 to $92.00 in a research note on Wednesday, July 26th. Morgan Stanley reiterated an “equal weight” rating and set a $88.00 price target (down previously from $90.00) on shares of HCA Holdings in a research note on Wednesday, July 26th. Finally, Citigroup Inc. cut their price target on HCA Holdings from $89.00 to $87.00 and set a “neutral” rating for the company in a research note on Wednesday, July 26th. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and sixteen have issued a buy rating to the company’s stock. HCA Holdings currently has an average rating of “Buy” and an average target price of $92.79.

HCA Holdings (NYSE HCA) traded up 2.46% during mid-day trading on Tuesday, reaching $77.04. The company had a trading volume of 2,692,137 shares. HCA Holdings has a one year low of $67.00 and a one year high of $91.03. The stock has a 50 day moving average price of $77.65 and a 200 day moving average price of $82.18. The company has a market capitalization of $27.83 billion, a P/E ratio of 10.33 and a beta of 0.62.

HCA Holdings (NYSE:HCA) last released its quarterly earnings results on Tuesday, July 25th. The company reported $1.75 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.80 by ($0.05). The company had revenue of $10.73 billion for the quarter, compared to analyst estimates of $10.76 billion. HCA Holdings had a net margin of 6.64% and a negative return on equity of 48.08%. HCA Holdings’s revenue for the quarter was up 4.0% on a year-over-year basis. During the same quarter last year, the firm posted $1.66 EPS. On average, equities analysts expect that HCA Holdings will post $7.11 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This piece was reported by American Banking News and is owned by of American Banking News. If you are reading this piece on another publication, it was stolen and republished in violation of US & international trademark & copyright laws. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2017/10/17/hca-holdings-inc-hca-downgraded-by-zacks-investment-research-to-sell.html.

In related news, insider Michael S. Cuffe sold 2,150 shares of HCA Holdings stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $79.87, for a total value of $171,720.50. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 2.90% of the company’s stock.

Several large investors have recently bought and sold shares of the stock. Banque Pictet & Cie SA raised its holdings in HCA Holdings by 73.9% during the 1st quarter. Banque Pictet & Cie SA now owns 67,235 shares of the company’s stock valued at $5,983,000 after acquiring an additional 28,562 shares during the period. Global X Management Co. LLC raised its holdings in HCA Holdings by 29.9% during the 1st quarter. Global X Management Co. LLC now owns 2,162 shares of the company’s stock valued at $192,000 after acquiring an additional 498 shares during the period. Banco Santander S.A. bought a new stake in HCA Holdings during the 1st quarter valued at $996,000. Meiji Yasuda Asset Management Co Ltd. raised its holdings in HCA Holdings by 66.2% during the 1st quarter. Meiji Yasuda Asset Management Co Ltd. now owns 7,960 shares of the company’s stock valued at $708,000 after acquiring an additional 3,170 shares during the period. Finally, Vanguard Group Inc. raised its holdings in HCA Holdings by 1.9% during the 1st quarter. Vanguard Group Inc. now owns 19,576,992 shares of the company’s stock valued at $1,742,157,000 after acquiring an additional 361,027 shares during the period. 73.76% of the stock is currently owned by institutional investors.

HCA Holdings Company Profile

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Get a free copy of the Zacks research report on HCA Holdings (HCA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for HCA Holdings (NYSE:HCA)

Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.